Delays in initial workflow cause delayed initiation of mechanical thrombectomy in patients with in-hospital ischemic stroke

Abstract

Objectives: The benefit of mechanical thrombectomy for acute ischemic stroke is highly time dependent. However, time to treatment is longer for in-hospital stroke patients than community-onset stroke patients. This study aimed to clarify the cause of this difference.

Methods: A retrospective single-center study was performed to analyze patients with large vessel occlusion who underwent mechanical thrombectomy between January 2017 and December 2019. Patients were divided into in-hospital stroke and community-onset stroke groups. Clinical characteristics and treatment time intervals were compared between groups.

Results: One hundred four patients were analyzed: 17 with in-hospital stroke and 87 with community-onset stroke. Patient characteristics did not significantly differ between groups. Median door (stroke recognition)-to-computed tomography time (36 min vs. 14 min, P<0.01) and door-to-puncture time (135 min vs. 117 min, P=0.02) were significantly longer in the in-hospital stroke group than the community-onset stroke group. However, median computed tomography-to-puncture time (104 min vs. 104 min, P=0.47) and puncture-to-reperfusion time (53 min vs. 38 min, P=0.17) did not significantly differ.

Conclusions: Longer door-to-puncture time in in-hospital stroke patients was mostly caused by longer door-to-computed tomography time, which is the initial part of the workflow. An in-hospital stroke protocol that places importance on early stroke specialist consultation and prompt transportation to the computed tomography scanner might hasten treatment and improve outcomes in patients with in-hospital stroke.

Introduction

Multiple randomized trials have established mechanical thrombectomy as the standard of care for eligible patients with large vessel occlusion.^1–7 Timely reperfusion is critical because earlier reperfusion improves functional outcomes: for every 30-minute delay, the absolute rate of a good outcome is reduced by 11%.^8–10

Although in-hospital stroke (IHS) is much less common than community-onset stroke (COS), it is a significant problem. Approximately 6.5% to 15.0% of all strokes occur in patients already in the hospital.^11,12 Previous reports have demonstrated significant delays in treatment and worse functional outcomes among patients with IHS.^13–17 Furthermore, patients with IHS often cannot receive intravenous recombinant tissue plasminogen activator (rt-PA) because of comorbidities or contraindications.^13,18,19 Therefore, mechanical thrombectomy plays a major role in many patients with IHS.

In this study, we aimed to clarify the cause of treatment delay in patients with IHS who underwent mechanical thrombectomy by comparing clinical features and treatment time intervals between IHS and COS patients.

Methods

Patient selection

This single-center retrospective study evaluated the angiographic and clinical data of 104 consecutive patients who underwent mechanical thrombectomy for large vessel occlusion stroke from January 2017 to December 2019. Large vessels were defined as the internal carotid artery, first or second segment of the middle cerebral artery, first segment of the posterior cerebral artery, basilar artery, and intracranial vertebral artery. IHS was defined as ischemic stroke occurring in a patient who had been hospitalized for more than 24 h.

Patients with acute ischemic stroke resulting from large vessel occlusion who were treated with mechanical thrombectomy were eligible for study inclusion. We excluded patients with re-occlusion after previous thrombectomy or large vessel occlusion during or after endovascular cerebral aneurysm or arteriovenous malformation treatment.

IHS protocol

Our IHS protocol is outlined as follows: Once hospital staff identifies a patient with suspected stroke, they first contact the attending physician and stroke specialist. Both visit the patient as soon as possible to arrange and coordinate neuroimaging and determine if rt-PA and/or mechanical thrombectomy are indicated.

Procedures

All procedures were performed using local anesthesia with a transfemoral approach. Intravenous heparin was administered and titrated to maintain an activated clotting time of two times the baseline value. A balloon guide catheter was inserted into the internal carotid artery or vertebral artery according to thrombus location. Mechanical thrombectomy was performed using a combined technique with both a stent retriever and aspiration catheter. Successful angiographic recanalization was defined as achieving thrombolysis in cerebral infarction (TICI) grade 2b or 3 flow.²⁰

Data collection and clinical outcomes

The following data were obtained and reviewed retrospectively from the medical records: patient age, sex, pre-morbid modified Rankin Scale (mRS) score, National Institutes of Health Stroke Scale (NIHSS) score on admission, location of the occluded vessel, and Alberta Stroke Programme Early Computed Tomography Score (ASPECTS).²¹ Stroke subtypes were classified according to the Trial of ORG 10172 in Acute Stroke Treatment criteria.²²

Clinical outcome was evaluated using mRS score at discharge. Good outcome was defined as mRS score 0–2; poor outcome was defined as mRS score 3–6. Successful revascularization was defined as post-procedural TICI grade ≥2b. Adverse events were defined as procedure-related serious adverse events (arterial perforation, arterial dissection, subarachnoid hemorrhage, and vasospasm) and intracerebral hemorrhage. Symptomatic intracranial hemorrhage was defined based on the European-Australasian Acute Stroke Study II criteria as clinical deterioration likely caused by a hemorrhage that caused a NIHSS score increase ≥4 points.²³

The following treatment time intervals were evaluated: (1) last well known (LWK) to door time (door time was considered stroke recognition time for patients with IHS), (2) door-to-computed tomography (CT) time, (3) door-to-needle time, (4) door-to-puncture time, (5) CT-to-puncture time, and (6) puncture-to-reperfusion time. For the IHS group, we also evaluated the time between stroke recognition and consultation with a stroke specialist.

This study was approved by the institutional ethics committee. The requirement for written informed consent for participation was waived due to the retrospective nature of the study. Patients were provided the opportunity to opt out of routine programmatic data analysis via the institutional website.

Statistical analyses

Statistical analyses were performed using open source EZR software. Continuous data are presented as means with standard deviation or medians with interquartile range. Categorical data are presented as numbers with percentage. Statistical comparisons were conducted using the Student’s t test, Mann–Whitney U test, or Fisher’s exact test as appropriate. P<0.05 was considered significant.

Results

During the study period, 112 patients with large vessel occlusion stroke underwent mechanical thrombectomy in our institution. Eight patients with re-occlusion after previous thrombectomy or large vessel occlusion after endovascular cerebral aneurysm or arteriovenous malformation treatment were excluded. Therefore, 104 patients were included for analysis: 17 with IHS and 87 with COS. Patient characteristics are presented in Table 1.

Table1 Characteristics of patients with in-hospital stroke and community-onset stroke

	IHS (n=17)	COS (n=87)	P-value
Age	76.6±8.3	74.6±12.8	0.53
Male	12 (70.6)	45 (51.7)	0.19
mRS score before onset	0 (0–2.0)	0 (0–1.5)	0.26
NIHSS score	12 (7–18)	20 (14–25)	0.06
ASPECTS	9 (7–10)	9 (8–10)	0.58
Hypertension	15 (88.2)	69 (79.3)	0.52
Dyslipidemia	8 (47.1)	40 (46.0)	1
Diabetes mellitus	5 (29.4)	21 (24.1)	0.76
Coronary artery disease	5 (29.4)	10 (11.5)	0.07
Smoking habit	13 (76.5)	49 (56.3)	0.18
Atrial fibrillation	7 (41.2)	56 (64.4)	0.10
Anticoagulation	5 (29.4)	18 (20.7)	0.52
rt-PA	2 (11.8)	44 (50.6)	<0.01
Site of occlusion
Internal carotid artery	5 (29.4)	22 (25.2)	0.77
M1	5 (29.4)	41 (47.1)	0.20
M2	5 (29.4)	18 (20.7)	0.52
Posterior circulation	2 (11.8)	6 (6.9)	0.61
Ischemic stroke subtype
cardioembolism	9 (52.9)	64 (73.6)	0.14
atherosclerosis	1 (5.9)	10 (11.5)	0.69
other specific-etiologies	4 (23.5)	1 (13.8)	<0.01
undetermined etiology	3 (17.6)	12 (13.8)	0.71

Data are presented as means±standard deviation, medians with interquartile range, or numbers with percentage.

ASPECTS, Alberta Stroke Programme Early Computed Tomography Score; COS, community-onset stroke; IHS, in-hospital stroke; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; rt-PA, recombinant tissue plasminogen activator; M1, first segment of middle cerebral artery; M2, second segment of middle cerebral artery

The IHS and COS groups did not significantly differ in terms of age, sex, pre-morbid mRS score, NIHSS score on admission, ASPECTS, anticoagulant medication, nor occluded vessel. The percentage of patients who received rt-PA was significantly lower in the IHS group than the COS group (12% vs. 51%, P<0.01). Approximately 85% of IHS patients who were recognized within 4.5 h of the LWK time had a contraindication to rt-PA. The most common contraindication was recent invasive treatment.

Cardioembolism was the most common ischemic stroke subtype in both IHS and COS patients. However, the distribution of subtypes differed between groups. The rate of other specific etiologies was significantly higher in patients with IHS than in patients with COS (24% vs. 14%, P<0.01). In the IHS group, the other specific-etiologies (n=4) included after lobectomy for lung cancer (n=3) and Trousseau syndrome (n=1). The detailed characteristics of the patients with IHS are illustrated in Table 2. The most frequent initial admission department was pulmonology (n=5), followed by the strokology (n=4) and cardiology (n=3) wards. The most common reason for admission was malignancy (n=8), followed by stroke (n=4).

Table2 Characteristics of patients with in-hospital stroke

	IHS (n=17)
Patient department at time of stroke
Pulmonology	5 (29.4)
Strokology	4 (23.5)
Cardiology	3 (17.6)
Gastroenterology	2 (11.8)
Urology	2 (11.8)
Emergency	1 (5.9)
Reason for admission
Surgery or treatment for malignancy	8 (47.1)
Lung	5 (29.4)
Prostate gland	1 (5.9)
Bladder	1 (5.9)
Liver	1 (5.9)
Stroke	4 (23.5)
Active cardiovascular disease	2 (11.8)
Surgical procedure	2 (11.8)
Infection	1 (5.9)

The time intervals from stroke recognition to treatment are depicted in Figure 1. The median LWK-to-door time (door time was considered stroke recognition time for patients with IHS) was shorter in the IHS group than the COS group but the difference was not significant (60 min vs. 80 min, P=0.23). The median door-to-CT time was significantly longer in the IHS group than the COS group (36 min vs. 14 min, P<0.01; Figure 1a). The median door-to-needle time was longer in the IHS group than the COS group but the difference was not significant (119 min vs. 63 min, P=0.23). The median door-to-puncture time was also significantly longer in the IHS group than the COS group (135 min vs. 117 min, P=0.02; Figure 1b). However, the times from median CT to puncture (104 min vs. 104 min, P=0.47), puncture to reperfusion (53 min vs. 38 min, P=0.17), and LWK to reperfusion (299 min vs. 274 min, P=0.55) did not significantly differ (Figure 1c, d). The median time from stroke recognition to stroke specialist consultation was 27 min. Neuroimaging was performed after consultation in five patients.

Figure 1

Comparison of treatment time intervals between the IHS and COS groups. Box-and-whisker plots of the time from (A) door to computed tomography (CT), (B) door to puncture, (C) CT to puncture, and (D) puncture to reperfusion. The horizontal line within the box represents the median and the top and bottom edges of each box indicate the interquartile range. Door-to-CT and door-to-puncture times were significantly longer in the IHS group than the COS group.

* Significant difference with P<0.05. ** Significant difference with P<0.01.

COS, community-onset stroke; IHS, in-hospital stroke; LWK, last well known

Treatment outcomes are presented in Table 3. The rates of successful recanalization (94% vs. 87%, P=0.69), adverse events (47% vs. 36%, P=0.42), and symptomatic intracranial hemorrhage (12% vs. 7%, P=0.62) did not significantly differ between the IHS and COS groups. Good outcome (mRS score 0–2) at discharge was achieved in six IHS patients (50%) and 26 COS patients (51%). Mortality did not significantly differ between the groups.

Table3 Comparison of treatment outcomes between the in-hospital stroke and community-onset stroke groups

	IHS (n=17)	COS (n=87)	P-value
Total number of passes	2 (1–3)	1 (1–2.5)	0.37
Successful recanalization	16 (94.1)	76 (87.4)	0.69
Adverse events	8 (47.1)	31 (36.0)	0.42
Symptomatic ICH	2 (11.8)	6 (7.0)	0.62
Good outcome at discharge	6 (35.3)	27 (31.0)	0.78
mRS score at discharge	4 (2–5)	4 (2–5)	0.55
Mortality	4 (23.5)	13 (14.9)	0.47

Data are presented as medians with interquartile range or numbers with percentage.

COS, community-onset stroke; ICH, intracranial hemorrhage; HIS, in-hospital stroke; mRS, modified Rankin Scale

Discussion

In the present study, we observed that door-to-puncture time was longer in IHS patients than COS patients. The main reason for this was significantly longer door-to-CT time, which is the initial part of the workflow. This phenomenon might be related to delayed consultation with the stroke specialist. The median time from recognition of symptoms to consultation with the stroke specialist was 27 min, and neuroimaging was performed after the consultation in some cases. Simultaneous consultations with the stroke specialist and attending physician are required as per our hospital protocol, although in actuality, consultation with the stroke specialist is often delayed. This delay can result in longer door-to-CT time. Previous studies have reported that delayed consultation with stroke specialists causes treatment delays in patients with IHS.^12,17,19,24

Moreover, several studies have reported improvements in assessment and treatment times after establishing an IHS protocol.^25–28 Three strategies were commonly employed in these studies: (1) implementing an IHS protocol, (2) repeated stroke education for key staff members, and (3) involving nurses with specialized stroke education in the initial response. Although our hospital had implemented an IHS protocol, stroke education for staff was insufficient and the initial response to IHS was limited to stroke specialists. These factors may have contributed to delayed treatment of IHS in our hospital. In the future, we plan to modify our IHS protocol algorithm to include stroke specialists and stroke-educated nurses in the initial stroke response. In addition, we plan to initiate a stroke education program for key staff members.

Several time intervals measured between stroke recognition and treatment in our study were longer in the IHS group than the COS group; however, outcomes did not significantly differ. This is because shorter LWK-to-door time compensated for the delays in neuroimaging and treatment in the IHS group. A well-designed IHS protocol that places importance on early consultation and prompt transportation to the CT scanner may lead to better outcomes in patients with IHS.

Thirteen patients in the present study experienced in-hospital large vessel occlusion that was recognized within 4.5 h. Among these, 11 (85%) patients had contraindications to rt-PA. Previous studies have also reported low utilization of rt-PA in IHS patients because of their comorbidities and contraindications.^19,24,29 Therefore, mechanical thrombectomy plays a more important role in IHS patients than COS patients. We suggest that IHS protocols should include the use of mechanical thrombectomy in addition to rt-PA.

IHS patients have different baseline characteristics than COS patients.^29,30 In this study, approximately half of the IHS patients had an underlying malignancy and the most frequent reason for hospital admission was surgery or treatment for malignancy. Moreover, there were four patients with IHS with other specific-etiologies of ischemic stroke subtypes, and the causes of three of them occurred after lobectomy for lung cancer. Cerebral embolism occurs in 0.2%–1.2% of patients who undergo lung cancer surgery; it typically develops following left upper lobectomy in patients with a long pulmonary vein stump.^31–33 Patients who are at high risk of ischemic stroke after lung cancer surgery should be identified before surgery and closely monitored neurologically afterward.

Our institution has approximately 1500 beds and a comprehensive stroke center that accepts stroke patients at all times. The distance to the CT and angiography rooms is long and transportation and communication can be difficult because of our hospital’s large size compared with community hospitals. This might explain the long CT-to-puncture times observed among our study patients in both the IHS and COS groups.

This study had several limitations, including its single-center retrospective design and relatively small sample size. In addition, all patients had large vessel occlusion stroke and were treated using thrombectomy alone. Patients with other types of stroke and those who received other treatment were not examined. Future prospective studies that include all cases of IHS and assess workflow times in detail are warranted.

Conclusions

Workflow times for mechanical thrombectomy were longer in IHS patients than COS patients in our institution. Delayed door-to-puncture time was mostly caused by delayed door-to-CT time, which is the initial part of the workflow. A well-designed IHS protocol that improves the initial part of the workflow might hasten treatment and improve outcomes in IHS patients.

Notes

Conflicts of Interest

The authors declare no conflicts of interest.

Funding

This study did not receive any specific grant from agencies in the public, commercial, or not-for-profit sectors.

References

• 1.    Berkhemer  OA,  Fransen  PSS,  Beumer  D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20.
• 2.    Goyal  M,  Demchuk  AM,  Menon  BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–1030.
• 3.    Jovin  TG,  Chamorro  A,  Cobo  E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306.
• 4.    Campbell  BCV,  Mitchell  PJ,  Kleinig  TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018.
• 5.    Mocco  J,  Zaidat  OO,  von Kummer  R, et al. Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone. Stroke 2016; 47: 2331–2338.
• 6.    Saver  JL,  Goyal  M,  Bonafe  A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–2295.
• 7.    Bracard  S,  Ducrocq  X,  Mas  JL,  Soudant  M,  Oppenheim  C,  Moulin  T,  Guillemin  F,  THRACE  investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016; 15: 1138–1147.
• 8.    Saver  JL. Time is brain—quantified. Stroke 2006; 37: 263–266.
• 9.    Emberson  J,  Lees  KR,  Lyden  P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929–1935.
• 10.    Khatri  P,  Abruzzo  T,  Yeatts  SD,  Nichols  C,  Broderick  JP,  Tomsick  TA,  IMS I and II  Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009; 73: 1066–1072.
• 11.    Blacker  DJ. In-hospital stroke. Lancet Neurol 2003; 2: 741–746.
• 12.    Farooq  MU,  Reeves  MJ,  Gargano  J,  Wehner  S,  Hickenbottom  S,  Majid  A, Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. In-hospital stroke in a statewide stroke registry. Cerebrovasc Dis 2008; 25: 12–20.
• 13.    Cumbler  E,  Wald  H,  Bhatt  DL,  Cox  M,  Xian  Y,  Reeves  M,  Smith  EE,  Schwamm  L,  Fonarow  GC. Quality of care and outcomes for in-hospital ischemic stroke: findings from the National Get With The Guidelines-Stroke. Stroke 2014; 45: 231–238.
• 14.    Caparros  F,  Ferrigno  M,  Decourcelle  A,  Hochart  A,  Moulin  S,  Dequatre  N,  Bodenant  M,  Hénon  H,  Cordonnier  C,  Leys  D. In-hospital ischaemic stroke treated with intravenous thrombolysis or mechanical thrombectomy. J Neurol 2017; 264: 1804–1810.
• 15.    Kimura  K,  Minematsu  K,  Yamaguchi  T. Characteristics of in-hospital onset ischemic stroke. Eur Neurol 2006; 55: 155–159.
• 16.    Park  HJ,  Cho  HJ,  Kim  YD,  Lee  DW,  Choi  HY,  Kim  SM,  Heo  JH. Comparison of the characteristics for in-hospital and out-of-hospital ischaemic strokes. Eur J Nuerol 2009; 16: 582-588.
• 17.    Alberts  MJ,  Brass  LM,  Perry  A,  Webb  D,  Dawson  DV. Evaluation times for patients with in-hospital strokes. Stroke 1993; 24: 1817–1822.
• 18.    Bekelis  K,  Missios  S,  Coy  S,  MacKenzie  TA. Comparison of outcomes of patients with inpatient or outpatient onset ischemic stroke. J Neurointerv Surg 2016; 8: 1221–1225.
• 19.    Saltman  AP,  Silver  FL,  Fang  J,  Stamplecoski  M,  Kapral  MK. Care and Outcomes of Patients With In-Hospital stroke. JAMA Neurol 2015; 72: 749–755.
• 20.    Tomsick  T,  Broderick  J,  Carrozella  J,  Khatri  P,  Hill  M,  Palesch  Y,  Khoury  J, Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008; 29: 582–587.
• 21.    Barber  PA,  Demchuk  AM,  Zhang  J,  Buchan  AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670–1674.
• 22.    Adams HP  Jr,  Bendixen  BH,  Kappelle  LJ,  Biller  J,  Love  BB,  Gordon  DL,  Marsh EE  3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993; 24: 35–41.
• 23.    Larrue  V,  von Kummer  RR,  Müller  A,  Bluhmki  E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001; 32: 438–441.
• 24.    Cumbler  E,  Murphy  P,  Jones  WJ,  Wald  HL,  Kutner  JS,  Smith  DB. Quality of care for in-hospital stroke: analysis of a statewide registry. Stroke 2011; 42: 207–210.
• 25.    Koge  J,  Matsumoto  S,  Nakahara  I, et al. Improving treatment times for patients with in-hospital stroke using a standardized protocol. J Neurol Sci 2017; 381: 68–73.
• 26.    Yoo  J,  Song  D,  Baek  JH,  Lee  K,  Jung  Y,  Cho  HJ,  Yang  JH,  Cho  HJ,  Choi  HY,  Kim  YD,  Nam  HS,  Heo  JH. Comprehensive code stroke program to reduce reperfusion delay for in-hospital stroke patients. Int J Stroke 2016; 11: 656–662.
• 27.    Cumbler  E,  Anderson  T,  Neumann  R,  Jones  WJ,  Brega  K. Stroke alert program improves recognition and evaluation time of in-hospital ischemic stroke. J Stroke Cerebrovasc Dis 2010; 19: 494–496.
• 28.    Kassardjian  CD,  Willems  JD,  Skrabka  K,  Nisenbaum  R,  Barnaby  J,  Kostyrko  P,  Selchen  D,  Saposnik  G. In-patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response Time. Stroke 2017; 48: 2176–2183.
• 29.    Chen  S,  Singh  RJ,  Kamal  N,  Hill  MD. Improving care for acute in-hospital ischemic stroke strokes—A narrative review. Int J Stroke 2018; 13: 905–912.
• 30.    Moradiya  Y,  Levine  SR. Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States. Stroke 2013; 44: 1903–1908.
• 31.    Hashimoto  H,  Usui  G,  Tsugeno  Y,  Sugita  K,  Amori  G,  Morikawa  T,  Inamura  K. Cerebral Thromboembolism after Lobectomy for Lung Cancer: Pathological Diagnosis and Mechanism of Thrombus Formation. Cancers 2019; 11: 488.
• 32.    Morinaga  Y,  Nii  K,  Sakamoto  K,  Inoue  R,  Mitsutake  T,  Hanada  H. Revascularization for In-Hospital Acute Ischemic Stroke After Video-Assisted Thoracic Surgery: Report of 2 Cases and Literature Review. World Neurosurg 2019; 129: 28–33.
• 33.    Usui  G,  Takayama  Y,  Hashimoto  H,  Katano  T,  Yanagiya  M,  Kusakabe  M,  Miura  T,  Matsumoto  J,  Horiuchi  H,  Okubo  S. Cerebral Embolism Caused by Thrombus in the Pulmonary Vein Stump after Left Lower Lobectomy: A Case Report and Literature Review. Intern Med 2019; 58: 1349–1354.